Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clopidogrel Loading Doses in STEMI Patients Undergoing PCI
NCT00827346Phase 3Completed
- Sponsor
- University of Ottawa Heart Institute
- Start
- Jan 2009
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clopidogrel in ST-segment elevation myocardial infarction (STEMI), sponsored by University of Ottawa Heart Institute. Started Jan 2009; status: completed.
02
Drugs
clopidogrel
03
Conditions
ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT00827346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00827346.